Silexion Therapeutics Corp — Form S-1/A
Filed August 10, 2026 · analyzed by the Registration Agent
S-1/A
— Neutral
significance 12/100
What the filing says
This S-1/A amendment exhibits three warrant forms (Series E Ordinary, Pre-Funded, and Placement Agent warrants) for Silexion Therapeutics Corp, a $4.6M-asset biotech. The forms are templates with blanks for share counts, exercise prices, and dates. A securities purchase agreement accompanies them. No dollar amounts, counterparties, or completed terms are specified—these are boilerplate documents awaiting completion.
Why this rating
Boilerplate warrant template exhibits in registration statement. No concrete deal, no financial terms, no material change disclosed. Routine SEC filing disclosure.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.